Biotech Beach

Found 77,188 articles

• La Jolla Pharmaceutical Company Release: Mechanism of Action for GS-100 in Lymphoma Published in Blood

  10/16/2012

• Kite Pharma, Inc. Partners With the National Cancer Institute to Develop Novel Cellular Immunotherapy Clinical Products

  10/16/2012

• EBD Group Collaborates With d&a Visual Insights™ to Offer Dynamic Visual Analytics of Life Science Partnering

  10/16/2012

• Transcepta Signs Multi-Year Contracts With Industry-Leading Organizations in the U.S. and Overseas

  10/16/2012

• Kythera Biopharmaceuticals Announces Closing of Initial Public Offering and Exercise of Underwriters’ Over-Allotment Option

  10/16/2012

• BG Medical Technologies Completes Process to Upgrade OTC Markets Listing

  10/16/2012

• ICU Medical, Inc. Reports Third Quarter 2012 Results

  10/16/2012

• Masimo Corporation to Report Third Quarter 2012 Financial Results After Market Close on October 30

  10/16/2012

• STAAR Surgical Company Announces Third Quarter 2012 Results Release Date and Conference Call and Webcast

  10/16/2012

• Vical Incorporated Appoints George J. Morrow to Board of Directors

  10/16/2012

• Medical Marijuana, Inc. Recaps Dixie X's Tripp Keber and Tamar Wise iCannabisRadio October 11 Interview

  10/16/2012

• Trius Therapeutics to Present Data From Tedizolid Clinical Studies at IDWeek Conference

  10/16/2012

• Insightra Medical Inc. Receives FDA Clearance for Inguinal Hernia System

  10/15/2012

• Nasal Spray to Combat Motion Sickness? NASA Signs Deal With Epiomed Therapeutics to Develop Treatment

  10/15/2012

• Fate Therapeutics Names Christian Weyer New CEO

  10/15/2012

• The Gores Group Snaps Up Therakos, Inc. for Undisclosed Amount

  10/15/2012

• Spinal Devices Maker NuVasive, Inc.'s Chickens Come Home to Roost

  10/15/2012

• Amgen Presents Several Sub-Analyses at American Society for Bone and Mineral Research From the Ongoing Open-Label Extension Study of the Pivotal Phase 3 Prolia Fracture Trial

  10/15/2012

• CytRx Corporation Advancing Aldoxorubicin (INNO-206) Development With Pharmacokinetic Study in Patients With Metastatic Solid Tumors

  10/15/2012

• PharmAria Announces Strategic Partnership With Celgene

  10/15/2012